Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1219741-21-5

Post Buying Request

1219741-21-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1219741-21-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1219741-21-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,1,9,7,4 and 1 respectively; the second part has 2 digits, 2 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1219741-21:
(9*1)+(8*2)+(7*1)+(6*9)+(5*7)+(4*4)+(3*1)+(2*2)+(1*1)=145
145 % 10 = 5
So 1219741-21-5 is a valid CAS Registry Number.

1219741-21-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-chloro-6-iodo-1,3-dihydrobenzimidazole-2-thione

1.2 Other means of identification

Product number -
Other names 5-Chloro-6-iodo-1H-benzo[d]imidazole-2(3H)-thione

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1219741-21-5 SDS

1219741-21-5Relevant articles and documents

Discovery of MK-8722: A Systemic, Direct Pan-Activator of AMP-Activated Protein Kinase

Feng, Danqing,Biftu, Tesfaye,Romero, F. Anthony,Kekec, Ahmet,Dropinski, James,Kassick, Andrew,Xu, Shiyao,Kurtz, Marc M.,Gollapudi, Anantha,Shao, Qing,Yang, Xiaodong,Lu, Ku,Zhou, Gaochao,Kemp, Daniel,Myers, Robert W.,Guan, Hong-Ping,Trujillo, Maria E.,Li, Cai,Weber, Ann,Sebhat, Iyassu K.

, p. 39 - 44 (2018/05/04)

5′-Adenosine monophosphate-activated protein kinase (AMPK) is a key regulator of mammalian energy homeostasis and has been implicated in mediating many of the beneficial effects of exercise and weight loss including lipid and glucose trafficking. As such,

PARASITICIDAL COMPOSITIONS COMPRISING BENZIMIDAZOLE DERIVATIVES, METHODS AND USES THEREOF

-

, (2013/11/05)

The invention relates to oral, topical or injectable compositions for combating liver fluke parasites in mammals, comprising at least one benzimidazole derivative active agent. The invention also provides for an improved method for eradicating and controlling liver fluke parasite infections and infestations in a mammal comprising administering the compositions of the invention to the mammal in need thereof.

NOVEL CYCLIC BENZIMIDAZOLE DERIVATIVES USEFUL ANTI-DIABETIC AGENTS

-

Page/Page column 81, (2010/05/14)

Novel compounds of the structural formula (I) are activators of AMP-protein kinase and are useful in the treatment, prevention and suppression of diseases mediated by the AMPK- activated protein kinase. The compounds of the present invention are useful in the treatment of Type 2 diabetes, hyperglycemia, metabolic syndrome, obesity, hypercholesterolemia, and hypertension.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1219741-21-5